SAREPTA THERAPEUTICSCS INC
SAREPTA THERAPEUTICSCS INC
Share · US8036071004 · SRPT · A1J1BH (XNMS)
Overview Financial Indicators
42,75 USD
7,93 % 3,14 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 22:45

Current Prices from SAREPTA THERAPEUTICSCS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
SRPT
USD
06.06.2025 22:45
42,75 USD
39,21 USD
+9,03 %
XLON: London
London
0L35.L
USD
06.06.2025 15:14
42,88 USD
39,21 USD
+9,36 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 14,00 % -8,56 % -59,50 % -66,65 % -65,33 % -71,11 %

Company Profile for SAREPTA THERAPEUTICSCS INC Share

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Invested Funds

The following funds have invested in: SAREPTA THERAPEUTICSCS INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
209,80
Percentage (%)
0,49 %

Company Data

Name SAREPTA THERAPEUTICSCS INC
Company Sarepta Therapeutics, Inc.
Symbol SRPT
Website https://www.sarepta.com
Primary Exchange XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A1J1BH
ISIN US8036071004
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mr. Douglas S. Ingram Esq.
Market Capitalization 5 Mrd.
Country United States of America
Currency USD
Employees 1,4 T
Address 215 First Street, 02142 Cambridge
IPO Date 2018-01-29

Stock Splits

Date Split
12.07.2012 1:6

ID Changes

Date From To
16.07.2012 AVII SRPT

Ticker Symbols

Name Symbol
Frankfurt AB3A.F
London 0L35.L
NASDAQ SRPT

More Shares

Investors who SAREPTA THERAPEUTICSCS INC hold also have the following shares in their portfolio:
AF-AM.F.AS.EQ.CO ADLC
AF-AM.F.AS.EQ.CO ADLC Fund
ALL.VERM.EU A (EUR)
ALL.VERM.EU A (EUR) Fund
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMAZON.CO INC
AMAZON.CO INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
INTEL CORP
INTEL CORP Share
ITERA ASA         NK 0,30
ITERA ASA NK 0,30 Share
MICRON TECHNOLOGIESLOGY INC
MICRON TECHNOLOGIESLOGY INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NVIDIA CORP
NVIDIA CORP Share
TESSCO TECHNOLOGIESLOGIES INC
TESSCO TECHNOLOGIESLOGIES INC Share
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025